Boston Scientific to Acquire Cardiac Mapping Company Cortex
Boston Scientific will acquire Cortex, Inc, integrating its OptiMap cardiac mapping technology for enhanced AF treatment.
Boston Scientific will acquire Cortex, Inc, integrating its OptiMap cardiac mapping technology for enhanced AF treatment.
The U.S. FDA has cleared the first fully disposable duodenoscope for marketing in the United States, the EXALT Model D Single-Use Duodenoscope from Marlboro, Mass.-based Boston Scientific Corp.
Boston Scientific will acquire Cortex, Inc, integrating its OptiMap cardiac mapping technology for enhanced AF treatment.